Safe Harbor
The presentation made during this meeting and other statements
by ArQule may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act with
respect to redesigning the drug discovery process, revenue growth,
and other future business objectives, opportunities and strategies.
Forward-looking statements are typically identified by words
such as “believe,” “expect,” “anticipate,” “intend,” “outlook,”
“position” and similar expressions, or future or conditional verbs
such as “will,” “should,” “would,” and “could.” Forward-looking
statements are subject to numerous assumptions, risks and
uncertainties. Forward-looking statements speak only as of today
and ArQule assumes no obligation to update them. Actual results may
differ materially from forward-looking statements or historical
performance due to the factors discussed in this presentation and
factors previously disclosed in ArQule’s SEC reports.